港股異動 | 中聯重科跌7% 第三季淨利同比下降46%
格隆匯10月29日丨港股中聯重科(1157.HK)跌7.95%,報5.67港元;A股中聯重科(000157.SZ)跌1.08%,報7.33元,總市值636億元。10月28日,公司昨日發佈2021年三季度報顯示,公司前三季度實現營收544.27億元,同比增長20.30%;實現歸母淨利潤57.51億元,同比增長1.13%。其中第三季度,公司實現營收119.78億元,同比降低27.04%;實現淨利潤9億元,同比下降46%。中泰證券發研報稱,第三季度,由於鋼材等原材料價格持續維持高位,疊加房地產、基建等下游需求減弱,公司主要工程機械產品銷量同比下滑明顯,導致第三季度經營業績出現下滑,下調中聯重科至“增持”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.